Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing
- PMID: 39644898
- DOI: 10.1016/j.cell.2024.11.002
Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing
Abstract
Glioblastomas are invasive brain tumors with high therapeutic resistance. Neuron-to-glioma synapses have been shown to promote glioblastoma progression. However, a characterization of tumor-connected neurons has been hampered by a lack of technologies. Here, we adapted retrograde tracing using rabies viruses to investigate and manipulate neuron-tumor networks. Glioblastoma rapidly integrated into neural circuits across the brain, engaging in widespread functional communication, with cholinergic neurons driving glioblastoma invasion. We uncovered patient-specific and tumor-cell-state-dependent differences in synaptogenic gene expression associated with neuron-tumor connectivity and subsequent invasiveness. Importantly, radiotherapy enhanced neuron-tumor connectivity by increased neuronal activity. In turn, simultaneous neuronal activity inhibition and radiotherapy showed increased therapeutic effects, indicative of a role for neuron-to-glioma synapses in contributing to therapeutic resistance. Lastly, rabies-mediated genetic ablation of tumor-connected neurons halted glioblastoma progression, offering a viral strategy to tackle glioblastoma. Together, this study provides a framework to comprehensively characterize neuron-tumor networks and target glioblastoma.
Keywords: brain tumor networks; brain tumors; cancer neuroscience; glioblastoma; invasion; neuron-to-glioma synapse; retrograde tracing; therapeutic rabies virus; therapeutic resistance.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.S.-R. reports funding from GSK, Pfizer, and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, and Grunenthal.
Comment in
-
Neuron-tumour networks targeted.Nat Rev Neurol. 2025 Feb;21(2):66. doi: 10.1038/s41582-025-01059-w. Nat Rev Neurol. 2025. PMID: 39820143 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
